Andrea Gropman MD

Division Chief for Neurogenetics and Neurodevelopmental Disabilities
Children's National
Washington DC

Editorial Board Member since 2024: Neurogenetic Disorders

Clinical Interest: Pediatric Neurogenetics

Dr. Andrea Gropman received her MD from the University of Massachusetts School of Medicine, completed a residency in Pediatrics at Johns Hopkins Hospital in Baltimore, Maryland, and subsequent fellowships in neurology/child neurology at George Washington University and Children’s National Hospital, Washington, DC, clinical and biochemical genetics at the National Institutes of Health, and a mini fellowship in neuroimaging and magnetic resonance spectroscopy at the Huntington Medical Research Institute in Pasadena, CA. She is board-certified in neurology/child neurology, genetics, biochemical genetics, and neurodevelopmental disabilities and is a Professor of Pediatrics, Neurology, Genomics, and Personalized Medicine at George Washington University

Dr. Gropman serves as the division chief for Neurogenetics and Neurodevelopmental disabilities. Dr. Gropman also is the PI for the Urea Cycle Rare Disorders Consortium and serves leadership roles on the RDCRN and in genetic, metabolic, and neurology societies. She has published over 200 articles and reviews and contributed chapters to classic textbooks in genetics and neurology and is one of the editors of the classic textbook, Swaiman’s Pediatric Neurology. Dr. Gropman is coauthor of the textbook, X and Y Chromosome Variations. Dr. Gropman's research has focused on several areas including inborn errors of metabolism, in which she is considered an international authority on neuroimaging and brain biomarkers in urea cycle disorders, mitochondrial epigenomics with longtime collaborator Dr. Anne Chiaramello, and chromosome disorders, including Smith Magenis syndrome and X and Y chromosome disorders. Dr. Gropman has dedicated her career to the care of children and adults with rare disease. Her talk will focus on her imaging work for urea cycle disorders and the impact on understanding the clinical phenotypes.

Dr. Gropman holds the Margaret O'Malley Endowed Chair in genetic medicine at Children's National Hospital. Dr. Gropman serves as the PI for the Urea Cycle Disorders consortium, one of the Rare Disease Clinical Research Networks, funded by NCATs and NICHD and NIDDK. She served a 3-year term as RDCRN co-chair. Dr. Gropman is the Chair of the Neurogenetics Special Interest group for the Child Neurology Society where she has also served on the awards committee, legislative affairs committee, and scientific selection committee. She is an associate editor for the Journal of Child Neurology and an editor of the Swaiman's Textbook of Child Neurology. She serves as the Chair of the Neurogenetics SIG at the American Neurological Society and the co-chair of the NG SIG at the American Academy of Neurology.

Dr. Gropman is relocating to St. Jude's Pediatric Research Hospital in the fall to direct a new neurometabolic translational research unit in the Center for Neurotherapeutics. She will be the Mark Tamer endowed chair in pediatric neurology.